Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
64th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE 2026)8 - 10 September 2026
Baseline characteristics, treatment patterns and 12-month real-world effectiveness of somapacitan in patients with growth hormone deficiency (GHD): data from GloBE-Reg
Authors:
Primoz Kotnik1,2, Malika Alimussina3, Suet Ching Chen4, Bradley S. Miller5, Alberto Pietropoli6, Dirk Schnabel7, Aristides Maniatis8, Abdulmoein Al-Agha9